| 前收市價 | 1.0300 |
| 開市 | 0.9900 |
| 買盤 | 0.3500 |
| 賣出價 | 1.5500 |
| 拍板 | 13.00 |
| 到期日 | 2024-09-20 |
| 今日波幅 | 0.9900 - 1.0300 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 120 |
ZacksDown -19.72% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM)
Adverum Biotechnologies (ADVM) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
ZacksAre Medical Stocks Lagging Ligand Pharmaceuticals (LGND) This Year?
Here is how Ligand Pharmaceuticals (LGND) and Adverum Biotechnologies (ADVM) have performed compared to their sector so far this year.
ZacksAdverum Biotechnologies (ADVM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Adverum Biotechnologies (ADVM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
